These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 25093614)

  • 1. Human paraoxonase 1 hydrolysis of nanomolar chlorpyrifos-oxon concentrations is unaffected by phenotype or Q192R genotype.
    Coombes RH; Meek EC; Dail MB; Chambers HW; Chambers JE
    Toxicol Lett; 2014 Oct; 230(1):57-61. PubMed ID: 25093614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toxicity of chlorpyrifos and chlorpyrifos oxon in a transgenic mouse model of the human paraoxonase (PON1) Q192R polymorphism.
    Cole TB; Walter BJ; Shih DM; Tward AD; Lusis AJ; Timchalk C; Richter RJ; Costa LG; Furlong CE
    Pharmacogenet Genomics; 2005 Aug; 15(8):589-98. PubMed ID: 16007003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paraoxonase 1 (PON1) status and substrate hydrolysis.
    Richter RJ; Jarvik GP; Furlong CE
    Toxicol Appl Pharmacol; 2009 Feb; 235(1):1-9. PubMed ID: 19071155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repeated gestational exposure of mice to chlorpyrifos oxon is associated with paraoxonase 1 (PON1) modulated effects in maternal and fetal tissues.
    Cole TB; Li WF; Co AL; Hay AM; MacDonald JW; Bammler TK; Farin FM; Costa LG; Furlong CE
    Toxicol Sci; 2014 Oct; 141(2):409-22. PubMed ID: 25070982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Relationship between PON1 phenotype and PON1-192 genotype in detoxification of three oxons by human liver.
    Mutch E; Daly AK; Williams FM
    Drug Metab Dispos; 2007 Feb; 35(2):315-20. PubMed ID: 17132760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repeated developmental exposure of mice to chlorpyrifos oxon is associated with paraoxonase 1 (PON1)-modulated effects on cerebellar gene expression.
    Cole TB; Beyer RP; Bammler TK; Park SS; Farin FM; Costa LG; Furlong CE
    Toxicol Sci; 2011 Sep; 123(1):155-69. PubMed ID: 21673326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paraoxonase 1 (PON1) modulates the toxicity of mixed organophosphorus compounds.
    Jansen KL; Cole TB; Park SS; Furlong CE; Costa LG
    Toxicol Appl Pharmacol; 2009 Apr; 236(2):142-53. PubMed ID: 19371602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The toxicity of mixtures of specific organophosphate compounds is modulated by paraoxonase 1 status.
    Cole TB; Jansen K; Park S; Li WF; Furlong CE; Costa LG
    Adv Exp Med Biol; 2010; 660():47-60. PubMed ID: 20221870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic and temporal determinants of pesticide sensitivity: role of paraoxonase (PON1).
    Furlong CE; Li WF; Richter RJ; Shih DM; Lusis AJ; Alleva E; Costa LG
    Neurotoxicology; 2000; 21(1-2):91-100. PubMed ID: 10794389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The PON1 gene and detoxication.
    Furlong CE; Li WF; Brophy VH; Jarvik GP; Richter RJ; Shih DM; Lusis AJ; Costa LG
    Neurotoxicology; 2000 Aug; 21(4):581-7. PubMed ID: 11022865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurobehavioral assessment of mice following repeated postnatal exposure to chlorpyrifos-oxon.
    Cole TB; Fisher JC; Burbacher TM; Costa LG; Furlong CE
    Neurotoxicol Teratol; 2012; 34(3):311-22. PubMed ID: 22425525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catalytic efficiency determines the in-vivo efficacy of PON1 for detoxifying organophosphorus compounds.
    Li WF; Costa LG; Richter RJ; Hagen T; Shih DM; Tward A; Lusis AJ; Furlong CE
    Pharmacogenetics; 2000 Dec; 10(9):767-79. PubMed ID: 11191881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PON1 status of farmworker mothers and children as a predictor of organophosphate sensitivity.
    Furlong CE; Holland N; Richter RJ; Bradman A; Ho A; Eskenazi B
    Pharmacogenet Genomics; 2006 Mar; 16(3):183-90. PubMed ID: 16495777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Paraoxonase 1 gene polymorphisms on organophosphate insecticide metabolism in Japanese pest control workers.
    Sato H; Ito Y; Ueyama J; Kano Y; Arakawa T; Gotoh M; Kondo T; Sugiura Y; Saito I; Shibata E; Kamijima M
    J Occup Health; 2016; 58(1):56-65. PubMed ID: 26549836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paraoxonase status and plasma butyrylcholinesterase activity in chlorpyrifos manufacturing workers.
    Albers JW; Garabrant DH; Berent S; Richardson RJ
    J Expo Sci Environ Epidemiol; 2010 Jan; 20(1):79-89. PubMed ID: 19223938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetically determined susceptibility to organophosphorus insecticides and nerve agents: developing a mouse model for the human PON1 polymorphism.
    Furlong CE; Li WF; Costa LG; Richter RJ; Shih DM; Lusis AJ
    Neurotoxicology; 1998; 19(4-5):645-50. PubMed ID: 9745924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of paraoxonase (PON1) L55M status requires both genotype and phenotype.
    Brophy VH; Jarvik GP; Richter RJ; Rozek LS; Schellenberg GD; Furlong CE
    Pharmacogenetics; 2000 Jul; 10(5):453-60. PubMed ID: 10898114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spectrophotometric assays for the enzymatic hydrolysis of the active metabolites of chlorpyrifos and parathion by plasma paraoxonase/arylesterase.
    Furlong CE; Richter RJ; Seidel SL; Costa LG; Motulsky AG
    Anal Biochem; 1989 Aug; 180(2):242-7. PubMed ID: 2479288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ratio of serum paraoxonase/arylesterase activity using an improved assay for arylesterase activity to discriminate PON1(R192) from PON1(Q192).
    Nakanishi M; Takanami Y; Maruyama T; Murata M; Motohashi Y; Nakano S; Uchida K; Maruyama C; Kyotani S; Tsushima M
    J Atheroscler Thromb; 2003; 10(6):337-42. PubMed ID: 15037822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of paraoxonase (PON1) status in pesticide sensitivity: genetic and temporal determinants.
    Furlong CE; Cole TB; Jarvik GP; Pettan-Brewer C; Geiss GK; Richter RJ; Shih DM; Tward AD; Lusis AJ; Costa LG
    Neurotoxicology; 2005 Aug; 26(4):651-9. PubMed ID: 16112327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.